Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

A Novel Digital Music-based Autonomous Personalized Walking Intervention to Improve Gait and Walking Automaticity in Parkinson Disease

Trial N/A Recruiting Aug. 23, 2026

A Digital Therapeutic Platform for Swallowing and Drooling Problems in Parkinson's

Trial Phase 3 Recruiting Aug. 23, 2026

tDCS of the Primary Motor Cortex to Improve Implicit Motor Sequence Learning in Parkinson's Disease

Trial N/A Completed Aug. 23, 2026

CnF-DBS for Levodopa-Resistant FOG

Trial N/A Not yet recruiting Aug. 23, 2026

An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

Trial Phase 2 Recruiting Aug. 23, 2026

Unilateral and Staged Bilateral Pallidothalamic Tractotomy Using Exablate MRgFUS in Advanced Parkinson's Disease.

Trial N/A Not yet recruiting Aug. 23, 2026

Cross-System Effects of Acute Intermittent Hypercapnia-Based Interventions in PD

Trial N/A Recruiting Aug. 20, 2026

Combined Genome and RNA Sequencing for Genetic Diagnosis of Parkinsonism

Trial N/A Recruiting Aug. 20, 2026

Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy

Trial Phase 2 Completed Aug. 20, 2026

Genetics and Aerobic Exercise to Slow Parkinson's Disease Trial

Trial N/A Recruiting Aug. 20, 2026

STN-tTIS With Different Intervention Intervals Versus Standard Medical Treatment for Parkinson's Disease

Trial N/A Recruiting Aug. 20, 2026

GBPDC: Gut-Brain in PD Consortium Master Protocol

Trial N/A Recruiting Aug. 20, 2026

A Two-Part Single and Multiple Ascending Dose Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LBT-3627 in Healthy Participants and in Participants With Parkinson's Disease.

Trial Phase 1 Recruiting Aug. 20, 2026

French Parkinson's Disease Cohort - NS-PARK

Trial N/A Recruiting Aug. 19, 2026

Telehealth in Lewy Body Dementia

Trial N/A Active, not recruiting Aug. 19, 2026

Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease

Trial N/A Completed Aug. 19, 2026

Personalized Real-Time DBS and PD Mechanisms

Trial Phase 4 Recruiting Aug. 19, 2026

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Trial Phase 4 Recruiting Aug. 18, 2026

Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients.

Trial Phase 2 Withdrawn Aug. 18, 2026

Research Into the Expression of the csgA-gene and How it Changes in Patients With Parkinson's Disease

Trial N/A Recruiting Aug. 18, 2026